The Briefing: Pepperdine’s Trademark Claim Against Netflix in “Running Point” Case Goes Under For Good
Episode 421 -- The Dangers of AI Mistakes
EEO-1 Reports, Remote Work, and Non-Compete Restrictions in Tennessee - Employment Law This Week®
The Briefing: UMG v. Quince: When Trending Audio Becomes Copyright Infringement
Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
'Urgent National Action to Save College Sports': Trump’s NIL Playbook — Highway to NIL Podcast
On June 2, 2026, President Trump signed an Executive Order titled "Promoting Advanced Artificial Intelligence Innovation and Security" (the "Order"). The Order represents the Administration's latest action in its broader...more
The UPC Court of Appeal has delivered an important ruling in Fujifilm v Kodak, confirming that the United Patent Court’s jurisdiction may extend to non-UPC European patent designations. The decision distinguishes between the...more
As data centers integrate numerous advanced technologies within a single operating environment, they are becoming a natural focal point for intellectual property (IP) scrutiny, including patent disputes, with patent...more
By now most people have heard that Hikma v. Amarin, No. 24–889 (June 4, 2026), was an overall favorable decision for skinny labeling. But what are the practical takeaways? Here we outline the facts and factors considered by...more
AI-Assisted Development Is Reshaping Software Ownership, Confidentiality and Litigation Risk - Artificial intelligence (AI) is rapidly transforming how software is developed. More than ever, engineers are no longer writing...more
In a unanimous opinion by Justice Ketanji Brown Jackson, the U.S. Supreme Court held that Amarin, the developer of Vascepa® (reference listed drug), failed to plausibly allege that Hikma actively induced infringement of...more
In April 2026, a complaint alleging “one of the most egregious examples of piracy in the medical technology industry” landed on the docket of the U.S. District Court for the Eastern District of Texas....more
Key Takeaways: In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, the Supreme Court reversed the Federal Circuit and held that a generic drug manufacturer’s FDA-compliant skinny label, combined with...more
On June 4, 2026, the United States Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. In its decision, the Supreme Court reversed the Federal Circuit, and held that Amarin’s complaint...more
Generative artificial intelligence has made it easier than ever to replicate someone’s voice or face without their consent, and the law has struggled to keep pace....more
The Supreme Court has issued a unanimous decision in Hikma v. Amarin, holding that Amarin did not meet its pleading burden of plausibly alleging that Hikma induced infringement of Amarin’s patents relating to reducing the...more
Generic drug manufacturers have greater protection from claims of induced infringement in “skinny label” cases following a unanimous 9-0 victory before the U.S. Supreme Court in Hikma Pharmaceuticals v. Amarin Pharma. Skinny...more
The Supreme Court issued a unanimous decision for Hikma in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. It reversed the Federal Circuit and held that Amarin failed to state a claim that Hikma induced infringement...more
The Senate passed the reconciliation 2.0 package, which funds ICE and CBP and includes no healthcare provisions. The bill now moves to the House, though Republican leadership cancelled Friday votes, postponing further action...more
Youth-Safety Debate Moves Down-Stack - Utah is the latest state to push online youth-safety regulation beyond social media platforms themselves. A new law (H.B. 498) requires stores to verify users’ ages and obtain...more
On June 2, 2026, the Federal Circuit issued a precedential decision in AGI SureTrack LLC v. Farmers Edge Inc. that delivered a split result — and a reminder that winning a patent case is not the same thing as collecting fees...more
A federal court recently denied a motion to dismiss a franchisor’s claims in Valenta Franchise LLC v. Innerworks LLC, 2026 WL 1453649 (D. Ariz. May 22, 2026)....more
The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a...more
Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR, claims are counted only once, whether they...more
Federal Treasury Enterprise v. Spirits International, No. 14-cv-712 (S.D.N.Y. May 15, 2026) - Recently, the Southern District of New York (“District Court”) denied Federal Treasury Enterprise’s (“FTE”) motion for partial...more
District court denies motion to dismiss copyright infringement claims filed against operator of generative AI platform Hailuo, holding defendants are subject to personal jurisdiction in U.S., and that movie studio plaintiffs...more
Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more
The Supreme Court held that inducement of patent infringement requires active, affirmative statements or actions encouraging infringement, not merely statements that could be read as encouraging infringement....more
In dispute over ownership of sound recordings by group Parliament-Funkadelic, Sixth Circuit holds that band member’s ownership claim did not accrue until 2020, when band leader, George Clinton, denied validity of 1976...more
Denosumab Challenged Claim Types in Litigation: Claims are counted in each litigation, so claims from the same patent challenged in multiple litigations are counted more than once. Within each litigation a claim is counted...more